Lynx, a leading fintech platform in healthcare, announced on February 6, 2025, that it had raised $27 million in its recent Series A funding round. The round was led by Flare Capital Partners and included participation by McKesson Ventures, .406 Ventures, Obvious Ventures, CVS Health Ventures, and Frist Cressey Ventures.
With the new funding, Lynx plans to accelerate growth and scale its operations. Specifically, Lynx will focus its efforts on Medicare Advantage supplemental benefits, Medicaid value-added benefits, ICHRA, enhancing Consumer – Directed Health (CDH) account administration and compliance, and streamlining the consumer experience and operations for benefits administrators and health plans.
Lynx Co-Founder and CEO Matthew Renfro commented on the company’s recent successes and innovations: “We’ve addressed critical challenges for major health plans, such as preventing January 1st debit card outages in Medicare Advantage programs, and enabling leading technology platforms managing consumer-directed health accounts to introduce unmatched flexibility and configurability to their platforms. Additionally, we are pioneering innovation in the rapidly growing ICHRA market, with the payment account of an estimated 10% of all ICHRAs having been built on the Lynx platform.”
He continued, noting that this latest funding round will “fuel our expansion across all channels, empowering us to continue driving innovation and delivering exceptional value to health plans, financial institutions, administrators, and members alike.”
See related materials: